DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 127 filers reported holding DYNE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $189,262 | -42.9% | 21,123 | -28.3% | 0.00% | 0.0% |
| Q2 2023 | $331,583 | -7.3% | 29,474 | -5.1% | 0.00% | 0.0% |
| Q1 2023 | $357,800 | +24.3% | 31,059 | +25.1% | 0.00% | 0.0% |
| Q4 2022 | $287,780 | -34.6% | 24,830 | -28.3% | 0.00% | 0.0% |
| Q3 2022 | $440,000 | +17.3% | 34,607 | -11.0% | 0.00% | 0.0% |
| Q1 2022 | $375,000 | -19.0% | 38,900 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $463,000 | -26.7% | 38,900 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $632,000 | -20.5% | 38,900 | +2.9% | 0.00% | -50.0% |
| Q2 2021 | $795,000 | – | 37,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |